Salim Hayek

hayek-salim
Adjunct Associate Professor
Email:
[email protected]
Available to mentor
Salim Hayek
hayek-salim
Adjunct Associate Professor
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • Center Memberships

    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Institute for Healthcare Policy and Innovation

    Recent Publications

    See All Publications
    • Journal Article
      Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use
      Porterfield LR, Nadeem S, Swanson D, Hayek SS, Vaughan EM. Current Atherosclerosis Reports, 2026 Dec 1; 28 (1): DOI:10.1007/s11883-026-01448-6
      PMID: 42470502
    • Journal Article
      SGLT2 inhibitors and cardiovascular outcomes in patients with diabetes following hematopoietic stem cell transplantation: A propensity-matched cohort study
      Yeo YH, Wong HKK, Tan JY, Ong TE, Vignarajah A, Koo TH, Vigneswaramoorthy N, Donisan T, Ayoub C, Okwuosa TM, Hayek SS. International Journal of Cardiology, 2026 Oct 15; 461: DOI:10.1016/j.ijcard.2026.134668
      PMID: 42435773
    • Journal Article
      High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors
      Ismail A, Vasbinder A, Bobby B, de Bever M, Vosooghi A, Pena-Valentin V, Shu L, Kalathoor S, Elangovan R, Jones R, Skibniewska J, Pizzo I, Catalan T, Farhat T, Kunkle P, Leja M, Hayek SS. Jacc Cardiooncology, 2026 Oct 1; 8 (5): 555 - 568. DOI:10.1016/j.jaccao.2026.07.012
    • Journal Article
      Long-term ambient air pollution is not associated with circulating soluble urokinase plasminogen activator receptor
      Ghazzal BZ, Ismail A, Huang Y, Gassett A, Farhat T, Elangovan R, Blakely P, Heckbert SR, Kaufman JD, Hayek SS. Environmental Epidemiology, 2026 Oct 1; 10 (5): e532 DOI:10.1097/EE9.0000000000000532
    • Journal Article
      suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
      Ismail A, Huang Y, Ghazzal B, Hutten C, Farhat T, Elangovan R, Bobby B, Kunkle P, Vasbinder A, Banerjee M, Quyyumi A, Pratley RE, Brooks MM, Pop-Busui R, Hayek SS. Diabetes Care, 2026 Oct 1; 49 (10): 1868 - 1876. DOI:10.2337/dc26-0899
      PMID: 42579565
    • Journal Article
      Correction to: uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome (10.1161/CIRCRESAHA.126.328563) (10.1161/CIRCRESAHA.126.328563)
      Hayek SS, Dryer SE. Circulation Research, 2026 Sep 11; 139 (7): DOI:10.1161/RES.0000000000000768
      PMID: 42721269
    • Journal Article
      Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study
      El Zarif T, Abou Alaiwi S, Nassar AH, Gariazzo E, Santo V, Garbo E, Aldea M, Paoloni F, Pannu S, Semaan K, Chehab O, Hoballah M, Navani V, Gao Y, Meyers D, Stukalin I, Mittra A, Li M, Jones N, Grynberg S, Shapira R, Vasbinder A, Hayek SS, Bou Farhat E, Eid M, Saad E, Freeman D, Parikh K, Desai A, Smith C, El-Am E, Nana FA, Foderaro S, Baena J, Herrera M, Cortellini A, Pinato DJ, Korolewicz J, Kim C, Sackstein P, Denu RA, Macaron W, Abdel-Wahab N, Neilan TG, Lima JAC, Florez N, Janne P, Ricciuti B, Pecci F, Choueiri TK, Kwan JM, Naqash AR. Oncologist, 2026 Sep 1; 31 (9): DOI:10.1093/oncolo/oyag277
      PMID: 42500986
    • Journal Article
      Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches
      Kochkarian T, Ismail A, Chaabo O, Motiwala A, Hayek SS. Catheterization and Cardiovascular Interventions, 2026 Sep 1; 108 (3): 946 - 965. DOI:10.1002/ccd.70733
      PMID: 42410742

    Featured News & Stories

    Pregnant woman in the hospital
    Health Lab

    Pregnant women hospitalized for COVID-19, and their newborns, have higher complication risk

    Pregnant women hospitalized for COVID-19, and their newborns, have higher complication risk.